XML 53 R41.htm IDEA: XBRL DOCUMENT
v3.10.0.1

COMMITMENTS AND CONTINGENCIES (Details) - USD ($) |  |  | 1 Months Ended | 12 Months Ended |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | ---
May 25, 2016 | Jun. 18, 2009 | Nov. 30, 2016 | May 31, 2018 | May 31, 2017 | Apr. 30, 2018 | Jan. 31, 2018 | Nov. 30, 2017 | Oct. 31, 2016
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Stock Issued During Period, Value, New Issues |  |  |  | $ 1,275,933 |  |  |  |  |
Vanderbilt University Medical Center [Member] |  |  |  |  |  |  |  |  |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Startup Costs |  |  |  |  |  |  |  |  | $ 85,000
University OF Michigan [Member] |  |  |  |  |  |  |  |  |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Startup Costs |  |  |  |  |  |  |  | $ 181,015 |
Beth Israel Deaconess Medical Center [Member] |  |  |  |  |  |  |  |  |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Startup Costs |  |  |  |  |  |  | $ 142,000 |  |
Guardian Angel Research Center [Member] |  |  |  |  |  |  |  |  |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Startup Costs |  |  |  |  |  | $ 75,400 |  |  |
Royalty Agreements [Member] |  |  |  |  |  |  |  |  |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Royalty Expense |  |  |  | $ 19,000 | $ 19,000 |  |  |  |
Royalty Expense Percentage Of Sales |  |  |  | 2.60% | 2.50% |  |  |  |
Exclusive Marketing License Agreement [Member] | US FDA [Member] |  |  |  |  |  |  |  |  |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Clearance Fees |  |  |  | $ 1,250,000 |  |  |  |  |
Conversion of Stock, Amount Converted |  |  |  | $ 250,000 |  |  |  |  |
Shares Issued, Price Per Share (in Dollars per share) |  |  |  | $ 3.00 |  |  |  |  |
Conversion of Stock, Shares Issued (in Shares) |  |  |  | 83,333 |  |  |  |  |
Exclusive Marketing License Agreement [Member] | Korean FDA [Member] |  |  |  |  |  |  |  |  |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Royalty Expense |  |  |  | $ 7,250,000 |  |  |  |  |
Agreement Term Period |  |  |  | 5 years |  |  |  |  |
Building In Irvine California [Member] |  |  |  |  |  |  |  |  |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Operating Lease Initiation Date |  | Sep. 01, 2009 |  |  |  |  |  |  |
Lease Expiration Date |  | Aug. 31, 2016 |  |  |  |  |  |  |
Property Available for Operating Lease [Member] |  |  |  |  |  |  |  |  |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Operating Leases, Rent Expense |  |  | $ 2,926 |  |  |  |  |  |
Lease Expiration Period |  |  | 10 years |  |  |  |  |  |
UNITED STATES | Property Available for Operating Lease [Member] |  |  |  |  |  |  |  |  |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Operating Leases, Rent Expense |  |  |  | $ 268,550 | $ 260,393 |  |  |  |
MEXICO | Property Available for Operating Lease [Member] |  |  |  |  |  |  |  |  |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Operating Leases, Rent Expense |  |  |  | $ 45,963 | $ 44,986 |  |  |  |
First Amendment To Lease [Member] | Building In Irvine California [Member] |  |  |  |  |  |  |  |  |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Lease Expiration Date |  |  |  | Aug. 31, 2021 |  |  |  |  |
Operating Leases, Rent Expense, Minimum Rentals |  |  |  | $ 21,000 |  |  |  |  |
Operating Leases, Rent Expense |  |  |  | 23,637 |  |  |  |  |
Security Deposit |  |  |  | $ 22,080 |  |  |  |  |
Exclusive Marketing License Agreement [Member] | Private Placement [Member] | Celtis Pharm Co., Ltd [Member] |  |  |  |  |  |  |  |  |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] |  |  |  |  |  |  |  |  |
Shares Issued, Price Per Share (in Dollars per share) | $ 3.00 |  |  |  |  |  |  |  |
Stock Issued During Period, Shares, New Issues (in Shares) | 333,334 |  |  |  |  |  |  |  |
Stock Issued During Period, Value, New Issues | $ 1,000,002 |  |  |  |  |  |  |  |

X
- Definition Term of the agreement. + References No definition available. + Details
Name: | bmra_AgreementTermPeriod
Namespace Prefix: | bmra_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | bmra_COMMITMENTSANDCONTINGENCIESDetailsLineItems
Namespace Prefix: | bmra_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the number of years in which the lease expires. + References No definition available. + Details
Name: | bmra_LeaseExpirationPeriod
Namespace Prefix: | bmra_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Date the operating lease was initiated, in CCYY-MM-DD format. + References No definition available. + Details
Name: | bmra_OperatingLeaseInitiationDate
Namespace Prefix: | bmra_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalty expenses expressed as a percentage of sales. + References No definition available. + Details
Name: | bmra_RoyaltyExpensePercentageOfSales
Namespace Prefix: | bmra_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The costs associated with the initial startup of an agreement. + References No definition available. + Details
Name: | bmra_StartUpCosts
Namespace Prefix: | bmra_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of expense in the period for clearance fees. + References No definition available. + Details
Name: | us-gaap_ClearanceFees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586 + Details
Name: | us-gaap_ConversionOfStockAmountConverted1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586 + Details
Name: | us-gaap_ConversionOfStockSharesIssued1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. + References No definition available. + Details
Name: | us-gaap_LeaseAndRentalExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Date which lease or group of leases is set to expire, in CCYY-MM-DD format. + References No definition available. + Details
Name: | us-gaap_LeaseExpirationDate1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=77902758&loc=d3e41499-112717 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 25 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=77910348&loc=d3e34039-112682 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 3) -URI http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697 + Details
Name: | us-gaap_OperatingLeasesRentExpenseMinimumRentals
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227 + Details
Name: | us-gaap_RoyaltyExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.8,17) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_SecurityDeposit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_VanderbiltUniversityMedicalCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_UniversityOFMichiganMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_BethIsraelDeaconessMedicalCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_GuardianAngelResearchCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=us-gaap_RoyaltyAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=bmra_ExclusiveMarketingLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_USFDAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_KoreanFDAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=bmra_BuildingInIrvineCaliforniaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=us-gaap_PropertyAvailableForOperatingLeaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_MX
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | bmra_LeaseAmendmentAxis=bmra_FirstAmendmentToLeaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | bmra_ContractsAxis=bmra_ExclusiveMarketingLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_CeltisPharmCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |